Pharmacologic treatment of acute pediatric methamphetamine toxicity

Anne-Michelle Ruha1, Mark C Yarema

  • 1Department of Medical Toxicology, Banner Good Samaritan Medical Center, Phoenix, AZ 85006-2502, USA. michelle.ruha@bannerhealth.com

Pediatric Emergency Care
|January 2, 2007
PubMed

Insights

Benzodiazepines and haloperidol effectively sedated pediatric patients with methamphetamine poisoning. This study found no serious adverse effects when using these medications for acute toxicity management.

Area of Science:

  • Pediatric Toxicology
  • Pharmacology
  • Emergency Medicine

Background:

  • Acute methamphetamine poisoning in children presents significant management challenges.
  • Agitation and altered mental status are common symptoms requiring prompt intervention.

Purpose of the Study:

  • To evaluate the safety and efficacy of benzodiazepines and haloperidol for sedating pediatric patients with acute methamphetamine poisoning.
  • To report clinical experience with these agents in intensive care settings.

Main Methods:

  • Retrospective chart review of 18 pediatric patients admitted for methamphetamine toxicity.
  • Analysis of drug dosages, clinical features, and laboratory results.
  • Recording of adverse events associated with haloperidol and benzodiazepines.

Main Results:

  • Eighteen patients received benzodiazepines with variable dosing.
  • Twelve patients were also treated with parenteral haloperidol.
  • No complications were observed from the administration of either haloperidol or benzodiazepines.

Conclusions:

  • Parenteral benzodiazepines and haloperidol are effective in controlling agitation in pediatric methamphetamine poisoning.
  • These agents appear to be safe for short-term use in this patient population.
  • Further research may explore optimal dosing and long-term outcomes.
Abstract

Related Concept Videos

Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...